Technical Analysis for BSX - Boston Scientific Corporation
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Historical BSX trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Fell Below 20 DMA | Bearish | 4.24% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 4.24% | |
Bollinger Band Squeeze | Range Contraction | 4.24% | |
Outside Day | Range Expansion | 4.24% | |
20 DMA Support | Bullish | 1.85% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 1.85% | |
Bollinger Band Squeeze | Range Contraction | 1.85% | |
BB Squeeze Started | Range Contraction | 1.85% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
Non-ADX 1,2,3,4 Pullback Entry | 2 days ago | |
Rose Above Previous Day's High | 2 days ago | |
Up 3% | 2 days ago | |
Rose Above 10 DMA | 2 days ago | |
Up 1 ATR | 2 days ago |
Get a Trading Assistant
- Earnings date: 02/03/2021
Boston Scientific Corporation Description
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. The company offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary technology products, such as balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices, and diagnostic catheters used in percutaneous transluminal coronary angioplasty; intraluminal ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. It also provides cardiac rhythm management devices consisting of implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; and implantable pacemaker systems, including implantable cardiac resynchronization therapy pacemaker systems to treat heart failure. In addition, the company offers endoscopy products, such as devices to treat diseases of the digestive and pulmonary systems; and peripheral interventions to diagnose and treat peripheral vascular disease. Further, it provides stone management products comprising ureteral stents, wires, lithotripsy devices, stone retrieval devices, sheaths, balloons, and catheters to treat urinary stone disease and benign prostatic hyperplasia; and mid-urethral sling products, sling materials, graft materials, pelvic floor reconstruction kits, and suturing devices for women's health. Additionally, it provides neuromodulation products used for the management of chronic pain; and medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart, such as radio frequency (RF) generators, steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. The company was founded in 1979 and is headquartered in Natick, Massachusetts.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Diseases Medical Technology Catheter Technology Products Catheters Heart Failure Ultrasound Chronic Pain Cardiology Interventional Radiology Prosthetics Ablation Artery Artery Disease Medical Technologies Protection Devices Endoscopy Hyperplasia Neuromodulation Cardiac Electrophysiology Interventional Cardiology Biomedical Engineering Coronary Artery Disease Peripheral Vascular Disease Balloon Catheter Benign Prostatic Hyperplasia Markets Medical Devices Percutaneous Angiography Angioplasty Lithotripsy Neuromodulation Products Embolic Protection Device Endoscopy Products Rhythm Disorders Synchronization Treatment Of Coronary Artery Disease
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 42.37 |
52 Week Low | 24.1 |
Average Volume | 9,936,587 |
200-Day Moving Average | 37.22 |
50-Day Moving Average | 37.18 |
20-Day Moving Average | 38.74 |
10-Day Moving Average | 38.99 |
Average True Range | 0.96 |
ADX | 14.18 |
+DI | 22.13 |
-DI | 21.36 |
Chandelier Exit (Long, 3 ATRs ) | 37.08 |
Chandelier Exit (Short, 3 ATRs ) | 39.18 |
Upper Bollinger Band | 40.03 |
Lower Bollinger Band | 37.44 |
Percent B (%b) | 0.81 |
BandWidth | 6.68 |
MACD Line | 0.49 |
MACD Signal Line | 0.56 |
MACD Histogram | -0.0708 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 41.77 | ||||
Resistance 3 (R3) | 41.58 | 40.64 | 41.40 | ||
Resistance 2 (R2) | 40.64 | 40.07 | 40.74 | 41.27 | |
Resistance 1 (R1) | 40.09 | 39.72 | 40.37 | 40.28 | 41.15 |
Pivot Point | 39.16 | 39.16 | 39.29 | 39.25 | 39.16 |
Support 1 (S1) | 38.60 | 38.59 | 38.88 | 38.80 | 37.93 |
Support 2 (S2) | 37.67 | 38.24 | 37.77 | 37.81 | |
Support 3 (S3) | 37.12 | 37.67 | 37.68 | ||
Support 4 (S4) | 37.31 |